全文获取类型
收费全文 | 4694篇 |
免费 | 372篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 171篇 |
妇产科学 | 101篇 |
基础医学 | 588篇 |
口腔科学 | 115篇 |
临床医学 | 601篇 |
内科学 | 942篇 |
皮肤病学 | 49篇 |
神经病学 | 473篇 |
特种医学 | 364篇 |
外科学 | 566篇 |
综合类 | 96篇 |
一般理论 | 1篇 |
预防医学 | 364篇 |
眼科学 | 78篇 |
药学 | 333篇 |
中国医学 | 18篇 |
肿瘤学 | 208篇 |
出版年
2023年 | 18篇 |
2022年 | 27篇 |
2021年 | 55篇 |
2020年 | 34篇 |
2019年 | 60篇 |
2018年 | 77篇 |
2017年 | 47篇 |
2016年 | 67篇 |
2015年 | 75篇 |
2014年 | 127篇 |
2013年 | 156篇 |
2012年 | 226篇 |
2011年 | 218篇 |
2010年 | 150篇 |
2009年 | 120篇 |
2008年 | 221篇 |
2007年 | 222篇 |
2006年 | 216篇 |
2005年 | 190篇 |
2004年 | 184篇 |
2003年 | 204篇 |
2002年 | 188篇 |
2001年 | 173篇 |
2000年 | 165篇 |
1999年 | 129篇 |
1998年 | 98篇 |
1997年 | 105篇 |
1996年 | 111篇 |
1995年 | 77篇 |
1994年 | 58篇 |
1993年 | 75篇 |
1992年 | 89篇 |
1991年 | 86篇 |
1990年 | 105篇 |
1989年 | 120篇 |
1988年 | 109篇 |
1987年 | 94篇 |
1986年 | 95篇 |
1985年 | 85篇 |
1984年 | 44篇 |
1983年 | 48篇 |
1982年 | 23篇 |
1981年 | 33篇 |
1980年 | 27篇 |
1979年 | 30篇 |
1978年 | 27篇 |
1977年 | 23篇 |
1976年 | 32篇 |
1975年 | 19篇 |
1973年 | 23篇 |
排序方式: 共有5100条查询结果,搜索用时 31 毫秒
191.
DTS Chang IA Thyer D Hayne DJ Katz 《Annals of the Royal College of Surgeons of England》2014,96(6):e23-e25
Australia has a large migrant population with variable fluency in English. Interpreting services help ensure that healthcare services are delivered appropriately to these populations. However, the use of professional interpreters in hospitals is expensive. There are also issues with service availability and convenience. Mobile devices containing software with translating abilities have promising potential to improve communication between patients and hospital staff as an adjunct to professional interpreters. It is highly convenient and inexpensive. There are concerns about the accuracy of the interpretation done with such software and more research needs to be carried out to support or allay these concerns. For now, clinically important and medicolegal related interpretation should be undertaken by professional interpreters whereas less crucial tasks may be performed with the help of interpreting software on mobile devices. 相似文献
192.
193.
194.
Gearoid M. McMahon Sarah R. Preis Shih-Jen Hwang Caroline S. Fox 《Journal of the American Society of Nephrology : JASN》2014,25(11):2633-2641
Early identification of CKD risk factors may allow risk factor modification and prevention of CKD progression. We investigated the hypothesis that risk factors are present ≥30 years before the diagnosis of CKD in a case-control study using data from the Framingham Offspring Study. Patients with incident CKD (eGFR≤60 ml/min per 1.73 m2) at examination cycles 6, 7, and 8 were age- and sex-matched 1:2 to patients without CKD at baseline (examination 5). CKD risk factors were measured at each examination cycle. Logistic regression models, adjusted for age, sex, and time period, were constructed to compare risk factor profiles at each time point between cases and controls. During follow-up, 441 new cases of CKD were identified and matched to 882 controls (mean age 69.2 years, 52.4% women). Those who ultimately developed CKD were more likely to have hypertension (odds ratio [OR], 1.76; 95% confidence interval [CI], 1.23 to 2.51), obesity (OR, 1.71; 95% CI, 1.14 to 2.59), and higher triglyceride levels (OR, 1.43; 95% CI, 1.12 to 1.83) 30 years before CKD diagnosis, and were more likely to have hypertension (OR, 1.38; 95% CI, 1.07 to 1.79), higher triglyceride levels (OR, 1.35; 95% CI, 1.11 to 1.64), lower HDLc (OR, 0.89; 95% CI, 0.81 to 0.97), and diabetes (OR, 2.90; 95% CI, 1.59 to 5.29) 20 years before CKD diagnosis. These findings demonstrate that risk factors for CKD are identifiable ≥30 years before diagnosis and suggest the importance of early risk factor identification in patients at risk for CKD. 相似文献
195.
Gearoid M. McMahon Matthias Olden Maija Garnaas Qiong Yang Xuan Liu Shih-Jen Hwang Martin G. Larson CKDGen Consortium Wolfram Goessling Caroline S. Fox 《Journal of the American Society of Nephrology : JASN》2014,25(12):2896-2905
Novel biomarkers are being investigated to identify patients with kidney disease. We measured a panel of 13 urinary biomarkers in participants from the Offspring Cohort of the Framingham Heart Study. Using an Affymetrix chip with imputation to 2.5 M single-nucleotide polymorphisms (SNPs), we conducted a GWAS of these biomarkers (n=2640) followed by exonic sequencing and genotyping. Functional studies in zebrafish were used to investigate histologic correlation with renal function. Across all 13 biomarkers, there were 97 significant SNPs at three loci. Lead SNPs at each locus were rs6555820 (P=6.7×10−49; minor allele frequency [MAF]=0.49) in HAVCR1 (associated with kidney injury molecule-1), rs7565788 (P=2.15×10−16; MAF=0.22) in LRP2 (associated with trefoil factor 3 [TFF3]), and rs11048230 (P=4.77×10−8; MAF=0.10) in an intergenic region near RASSF8 (associated with vascular endothelial growth factor). Validation in the CKDGen Consortium (n=67,093) showed that only rs7565788 at LRP2, which encodes megalin, was associated with eGFR (P=0.003). Sequencing of exons 16–72 of LRP2 in 200 unrelated individuals at extremes of urinary TFF3 levels identified 197 variants (152 rare; MAF<0.05), 31 of which (27 rare) were nonsynonymous. In aggregate testing, rare variants were associated with urinary TFF3 levels (P=0.003), and the lead GWAS signal was not explained by these variants. Knockdown of LRP2 in zebrafish did not alter the renal phenotype in static or kidney injury models. In conclusion, this study revealed common variants associated with urinary levels of TFF3, kidney injury molecule-1, and vascular endothelial growth factor and identified a cluster of rare variants independently associated with TFF3.Serum creatinine, as used in most GFR estimating equations, is the primary biomarker of CKD.1 Creatinine has significant limitations as a biomarker. It is insensitive to early declines in kidney function, and there are important extrarenal factors that influence its concentration, thus increasing the potential for misclassification when it is used to diagnose renal disease.2 As a result, novel biomarkers are being investigated that could allow earlier and more accurate diagnosis of CKD.3 It is likely, however, that these biomarkers also have non-GFR determinants, including genetic factors. For example, levels of cystatin C, a novel GFR biomarker, are known to be influenced by both nongenetic factors, such as adiposity and the metabolic syndrome,4 and the presence of specific genetic variants in the cystatin C-gene cluster.5Genome-wide association studies (GWAS) allow for the evaluation of genetic associations of biomarkers in an unbiased manner. These studies could illuminate previously unrecognized pathways for CKD pathogenesis, thus identifying new potential molecular targets for therapeutic intervention. Multiple variants have been identified in association with kidney function through GWAS,6 whereas a variant in CUBN encoding cubilin, a proximal tubular transport protein, has been associated with albuminuria.7 Recently, a GWAS identified a locus at PTGDS in association with another kidney biomarker, β-trace protein.8To gain additional insight into biologic pathways of renal function and kidney injury, we measured a panel of 13 urinary biomarkers in participants from the Framingham Heart Study (FHS) and performed a GWAS of their levels. Here, we report the primary results from these studies as well as follow-up work to identify whether rare variants in LRP2 are associated with levels of trefoil factor 3 (TFF3). 相似文献
196.
Alyssa T. Pyke Neelima Nair Andrew F. van den Hurk Peter Burtonclay Son Nguyen Jean Barcelon Carol Kistler Sanmari Schlebusch Jamie McMahon Frederick Moore 《Viruses》2021,13(6)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of COVID-19, is a readily transmissible and potentially deadly pathogen which is currently re-defining human susceptibility to pandemic viruses in the modern world. The recent emergence of several genetically distinct descendants known as variants of concern (VOCs) is further challenging public health disease management, due to increased rates of virus transmission and potential constraints on vaccine effectiveness. We report the isolation of SARS-CoV-2 VOCs imported into Australia belonging to the B.1.351 lineage, first described in the Republic of South Africa (RSA), and the B.1.1.7 lineage originally reported in the United Kingdom, and directly compare the replication kinetics of these two VOCs in Vero E6 cells. In this analysis, we also investigated a B.1.1.7 VOC (QLD1516/2021) carrying a 7-nucleotide deletion in the open reading frame 7a (ORF7a) gene, likely truncating and rendering the ORF7a protein of this virus defective. We demonstrate that the replication of the B.1.351 VOC (QLD1520/2020) in Vero E6 cells can be detected earlier than the B.1.1.7 VOCs (QLD1516/2021 and QLD1517/2021), before peaking at 48 h post infection (p.i.), with significantly higher levels of virus progeny. Whilst replication of the ORF7a defective isolate QLD1516/2021 was delayed longer than the other viruses, slightly more viral progeny was produced by the mutant compared to the unmutated isolate QLD1517/2021 at 72 h p.i. Collectively, these findings contribute to our understanding of SARS-CoV-2 replication and evolutionary dynamics, which have important implications in the development of future vaccination, antiviral therapies, and epidemiological control strategies for COVID-19. 相似文献
197.
Ramon Z. Shaban Cecilia Li Matthew V. N. O'Sullivan John Gerrard Rhonda L. Stuart Joanne Teh Nicole Gilroy Tania C. Sorrell Elizabeth White Shopna Bag Kate Hackett Sharon C. A. Chen Jen Kok Dominic E. Dwyer Jonathan R. Iredell Susan Maddocks Patricia Ferguson Kavita Varshney Ian Carter Ruth Barratt Mark Robertson Sai R. Baskar Caren Friend Roselle S. Robosa Cristina Sotomayor‐Castillo Shizar Nahidi Deborough A. Macbeth Kylie A. D. Alcorn Andre Wattiaux Frederick Moore Jamie McMahon William Naughton Tony M. Korman Mike Catton Rupa Kanapathipillai Finn Romanes Emily Rowe Jennifer Catford Brendan Kennedy Ming Qiao David Shaw 《Internal medicine journal》2021,51(1):42-51
198.
Sinu Bessy Abraham Siddharth Arunachalam Alex Zhong Pratik Agrawal Ohad Cohen Chantal M. McMahon 《Journal of diabetes science and technology》2021,15(1):91
Background:Most standalone real-time continuous glucose monitoring (RT-CGM) systems provide predictive low and high sensor glucose (SG) threshold alerts. The durations and risk of low and high SG excursions following Guardian™ Connect CGM system predictive threshold alerts were evaluated.Methods:Continuous glucose monitoring system data uploaded between January 2, 2017 and May 22, 2018 by 3133 individuals using multiple daily injections (MDIs) or continuous subcutaneous insulin infusion (CSII) therapy were deidentified and retrospectively analyzed. Glucose excursions were defined as SG values that went beyond a preset low or high SG threshold for ≥15 minutes. For a control group, thresholds were based on the median of the low SG threshold limit (70 mg/dL) and the high SG threshold limit (210 mg/dL) preset by all system users. During periods when alerts were not enabled, timestamps were identified when a predictive alert would have been triggered. The time before low horizon was 17.5 minutes and the time before high horizon was 15 minutes, of all users who enabled alerts. Excursions occurring after a low SG or high SG predictive alert were segmented into prevented, ≤20, 20-60, and >60 minutes.Results:Excursions were prevented after 59% and 39% of low and high SG predictive alerts, respectively. The risk of a low or high excursion occurring was 1.9 (P < 0.001, 95% CI, 1.88-1.93) and 3.3 (P < 0.001, 95% CI, 3.20-3.30) times greater, respectively, when alerts were not enabled.Conclusions:The predictive alerts of the RT-CGM system under study can help individuals living with diabetes prevent some real-world low and high SG excursions. This can be especially important for those unable to reach or maintain glycemic control with basic RT-CGM or CSII therapy. 相似文献
199.
We have developed a general quenched-flow approach to study platelet function as early as 0.3 seconds after stimulation. Phosphorylation of 20- and 40-kd proteins has been analyzed during the first five seconds of platelet response to thrombin from 0.1 to 5.0 U/mL and compared with the progress of aggregation and serotonin secretion. The onset time for aggregation and phosphorylation of both proteins was less than one second, although with lowest (less than 0.5 U/mL) thrombin levels, a lag of up to 0.6 seconds occurred before 40K phosphorylation increased. The thrombin sensitivity of aggregation and 20K phosphorylation was approximately twice that of 40K phosphorylation, with Ka values of 0.51 and 0.53 v 1.10 U/mL, respectively. External calcium was necessary for maximal 20K phosphorylation, since EDTA inhibited this by 30%. The 40K phosphorylation was not affected by EDTA. Platelet activation by thrombin thus induced biochemical changes well before one second. The quenched-flow approach may help to reveal relationships between phospholipase activation, calcium fluxes, and protein phosphorylation during these early periods of platelet function. 相似文献
200.
This report describes the production and characterization of 13 rodent monoclonal antibodies to the human erythrocyte anion transport protein AE1 (syn. band 3). Eleven antibodies (4 murine and 7 rat) recognize epitopes dependent on the integrity of the third extracellular loop of the protein. Two antibodies (1 murine and 1 rat) recognize epitopes on the N-terminal cytoplasmic domain. Quantitative binding studies using radioiodinated IgG and Fab fragments of antibodies to extracellular epitopes on AE1 ranged from 77,000 to 313,000 (IgG) and from 241,000 to 772,000 (Fab) molecules bound at saturation. The results indicate that the epitopes recognized by different antibodies vary in their accessibility and suggest that there is heterogeneity in the organization of individual AE1 molecules in the red blood cell membrane. Quantitative binding studies on South East Asian ovalocytes using several antibodies to AE1 and an anti-Wrb show a marked reduction in the number of antibody molecules bound at saturation. These results are consistent with the existence of highly cooperative interactions between transmembrane domains of AE1 in normal erythrocytes and the disruption of these interactions in the variant AE1 found in South East Asian ovalocytes. 相似文献